4:58 PM
 | 
Aug 30, 2013
 |  BC Extra  |  Company News

Aubagio gets European approval for MS

The European Commission approved an MAA from Sanofi (Euronext:SAN; NYSE:SNY) for Aubagio teriflunomide to treat relapsing-remitting multiple sclerosis (RRMS). Sanofi said it plans to launch Aubagio in Europe "in the coming months," with...

Read the full 152 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >